• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠纤维化。

Intestinal fibrosis.

机构信息

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.

出版信息

Mol Aspects Med. 2019 Feb;65:100-109. doi: 10.1016/j.mam.2018.10.003. Epub 2018 Nov 2.

DOI:10.1016/j.mam.2018.10.003
PMID:30385174
Abstract

Extensive tissue fibrosis is the end-stage process of a number of chronic conditions affecting the gastrointestinal tract, including inflammatory bowel disease (Crohn's disease, ulcerative colitis), ulcerative jejunoileitis, and radiation enteritis. Fibrogenesis is a physiological, reparative process that may become harmful as a consequence of the persistence of a noxious agent, after an excessive duration of the healing process. In this case, after replacement of dead or injured cells, fibrogenesis continues to substitute normal parenchymal tissue with fibrous connective tissue, leading to uncontrolled scar formation and, ultimately, permanent organ damage, loss of function, and/or strictures. Several mechanisms have been implicated in sustaining the fibrogenic process. Despite their obvious etiological and clinical distinctions, most of the above-mentioned fibrotic disorders have in common a persistent inflammatory stimulus which sustains the production of growth factors, proteolytic enzymes, and pro-fibrogenic cytokines that activate both non-immune (i.e., myofibroblasts, fibroblasts) and immune (i.e., monocytes, macrophages, T-cells) cells, the interactions of which are crucial in the progressive tissue remodeling and destroy. Here we summarize the current status of knowledge regarding the mechanisms implicated in gut fibrosis with a clinical approach, also focusing on possible targets of antifibrogenic therapies.

摘要

广泛的组织纤维化是许多影响胃肠道的慢性疾病的终末期过程,包括炎症性肠病(克罗恩病、溃疡性结肠炎)、溃疡性空肠回肠炎和放射性肠炎。纤维化是一种生理修复过程,但如果有害因子持续存在,或者愈合过程过长,它可能会变得有害。在这种情况下,在替换死亡或受损细胞后,纤维化继续用纤维结缔组织替代正常实质组织,导致不受控制的瘢痕形成,最终导致永久性器官损伤、功能丧失和/或狭窄。有几个机制被认为与维持纤维化过程有关。尽管上述大多数纤维化疾病在病因和临床方面存在明显差异,但它们都有一个共同的特点,即持续的炎症刺激,这种刺激持续产生生长因子、蛋白水解酶和促纤维化细胞因子,激活非免疫(即肌成纤维细胞、成纤维细胞)和免疫(即单核细胞、巨噬细胞、T 细胞)细胞,这些细胞的相互作用在进行性组织重塑和破坏中至关重要。在这里,我们从临床角度总结了与肠道纤维化相关的机制的最新知识,还重点介绍了抗纤维化治疗的可能靶点。

相似文献

1
Intestinal fibrosis.肠纤维化。
Mol Aspects Med. 2019 Feb;65:100-109. doi: 10.1016/j.mam.2018.10.003. Epub 2018 Nov 2.
2
Recent advances in intestinal fibrosis.肠道纤维化的最新进展
Mol Aspects Med. 2024 Apr;96:101251. doi: 10.1016/j.mam.2024.101251. Epub 2024 Feb 14.
3
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.心脏纤维化:细胞生物学机制、分子途径和治疗机会。
Mol Aspects Med. 2019 Feb;65:70-99. doi: 10.1016/j.mam.2018.07.001. Epub 2018 Aug 2.
4
Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.体外抑制成纤维细胞激活蛋白可恢复平衡的细胞外基质并减少克罗恩病狭窄处的纤维化。
Inflamm Bowel Dis. 2018 Jan 18;24(2):332-345. doi: 10.1093/ibd/izx008.
5
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications.器官和组织纤维化:分子信号、细胞机制及转化意义。
Mol Aspects Med. 2019 Feb;65:2-15. doi: 10.1016/j.mam.2018.06.003. Epub 2018 Jun 30.
6
Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.特色文章:TGF-β1 通过控制细胞外基质硬度诱导人心肌成纤维细胞分化为肌成纤维细胞。
Exp Biol Med (Maywood). 2018 Apr;243(7):601-612. doi: 10.1177/1535370218761628. Epub 2018 Mar 4.
7
Human Fibrotic Diseases: Current Challenges in Fibrosis Research.人类纤维化疾病:纤维化研究中的当前挑战
Methods Mol Biol. 2017;1627:1-23. doi: 10.1007/978-1-4939-7113-8_1.
8
The fate of myofibroblasts during the development of fibrosis in Crohn's disease.肌成纤维细胞在克罗恩病纤维化发展过程中的命运。
J Dig Dis. 2020 Jun;21(6):326-331. doi: 10.1111/1751-2980.12852.
9
Cellular and molecular mechanisms of intestinal fibrosis.肠道纤维化的细胞和分子机制。
World J Gastroenterol. 2012 Jul 28;18(28):3635-61. doi: 10.3748/wjg.v18.i28.3635.
10
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.炎症性肠病中肠肌成纤维细胞对金属蛋白酶组织抑制因子-1和基质金属蛋白酶的表达与调控
Am J Pathol. 2003 Apr;162(4):1355-60. doi: 10.1016/S0002-9440(10)63931-4.

引用本文的文献

1
Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with crohn's disease.PRO-C16( XVI型胶原蛋白形成)的血清学评估反映了克罗恩病患者的肠道纤维狭窄性狭窄。
BMC Gastroenterol. 2025 Aug 8;25(1):568. doi: 10.1186/s12876-025-04146-w.
2
Routine Blood Examination Predicts the Course of Disease in Patients with Pseudoexfoliation.血常规检查可预测假性剥脱综合征患者的疾病进程。
Medicina (Kaunas). 2025 Apr 2;61(4):652. doi: 10.3390/medicina61040652.
3
Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies.
炎症性肠病中炎症与纤维化的相互作用:机制、进展及治疗策略
Front Pharmacol. 2025 Feb 28;16:1530797. doi: 10.3389/fphar.2025.1530797. eCollection 2025.
4
From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases - Opportunity or Challenge?从炎性小体到细胞焦亡:慢性肠道疾病中的分子机制——机遇还是挑战?
J Inflamm Res. 2025 Mar 7;18:3349-3360. doi: 10.2147/JIR.S498703. eCollection 2025.
5
Cannabidiol Alleviates Intestinal Fibrosis in Mice with Ulcerative Colitis by Regulating Transforming Growth Factor Signaling Pathway.大麻二酚通过调节转化生长因子信号通路减轻溃疡性结肠炎小鼠的肠道纤维化。
J Inflamm Res. 2025 Jan 2;18:1-15. doi: 10.2147/JIR.S485007. eCollection 2025.
6
Perspectives on the extracellular matrix in inflammatory bowel disease and bowel decellularization protocols.炎症性肠病中的细胞外基质及肠脱细胞方案的研究视角
World J Exp Med. 2024 Dec 20;14(4):97179. doi: 10.5493/wjem.v14.i4.97179.
7
Co-Mn Complex Oxide Nanoparticles as Potential Reactive Oxygen Species Scavenging Agents for Pulmonary Fibrosis Treatment.钴锰复合氧化物纳米颗粒作为潜在的活性氧物种清除剂用于肺纤维化治疗。
Molecules. 2024 Oct 29;29(21):5106. doi: 10.3390/molecules29215106.
8
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.植物化学物质作为炎症性肠病中肠纤维化的有前途的治疗方法:批判性评价。
Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633.
9
Pathways regulating intestinal stem cells and potential therapeutic targets for radiation enteropathy.调控肠道干细胞的途径及放射性肠炎的潜在治疗靶点。
Mol Biomed. 2024 Oct 10;5(1):46. doi: 10.1186/s43556-024-00211-0.
10
Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease.Nrf2/HO-1在炎症性肠病中的作用机制及治疗意义
Antioxidants (Basel). 2024 Aug 20;13(8):1012. doi: 10.3390/antiox13081012.